Bosh sahifaNBTX • NASDAQ
add
Nanobiotix SA - ADR
Yopilish kursi
5,30 $
Kunlik diapazon
5,26 $ - 5,50 $
Yillik diapazon
4,14 $ - 11,00 $
Bozor kapitalizatsiyasi
241,05 mln USD
Oʻrtacha hajm
7,22 ming
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (EUR) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Daromad | 16,46 mln | 854,89% |
Joriy xarajat | 15,89 mln | 31,06% |
Sof foyda | -5,80 mln | 62,19% |
Sof foyda marjasi | -35,25 | 96,04% |
Har bir ulushga tushum | — | — |
EBITDA | 706,50 ming | 106,89% |
Amaldagi soliq stavkasi | -1,02% | — |
Balans
Jami aktivlari
Jami passivlari
| (EUR) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 75,28 mln | 81,90% |
Jami aktivlari | 93,90 mln | 57,10% |
Jami passivlari | 95,74 mln | 10,28% |
Umumiy kapital | -1,84 mln | — |
Tarqatilgan aksiyalar | 47,11 mln | — |
Narxi/balansdagi bahosi | -132,50 | — |
Aktivlardan daromad | 1,52% | — |
Kapitaldan daromad | 2,92% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (EUR) | dek, 2023info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -5,80 mln | 62,19% |
Operatsiyalardan naqd pul | 2,40 mln | 124,50% |
Sarmoyadan naqd pul | -11,00 ming | -125,88% |
Moliyadan naqd pul | 24,45 mln | 2 380,14% |
Naqd pulning sof oʻzgarishi | 26,83 mln | 348,02% |
Boʻsh pul | 409,38 ming | 106,66% |
Haqida
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
CEO
Tashkil etilgan
2003
Sayt
Xodimlar soni
102
